| Literature DB >> 29371683 |
Yvonne Shao1, McKenzie Shaw1, Kaitlin Todd1, Maria Khrestian1, Giana D'Aleo1, P John Barnard2, Jeff Zahratka1, Jagan Pillai3, Chang-En Yu4, C Dirk Keene4, James B Leverenz3, Lynn M Bekris5.
Abstract
The apolipoprotein E (APOE) ε4 allele is the major genetic risk factor for Alzheimer's disease (AD). Multiple regulatory elements, spanning the extended TOMM40-APOE-APOC2 region, regulate gene expression at this locus. Regulatory element DNA methylation changes occur under different environmental conditions, such as disease. Our group and others have described an APOE CpG island as hypomethylated in AD, compared to cognitively normal controls. However, little is known about methylation of the larger TOMM40-APOE-APOC2 region. The hypothesis of this investigation was that regulatory element methylation levels of the larger TOMM40-APOE-APOC2 region are associated with AD. The aim was to determine whether DNA methylation of the TOMM40-APOE-APOC2 region differs in AD compared to cognitively normal controls in post-mortem brain and peripheral blood. DNA was extracted from human brain (n = 12) and peripheral blood (n = 67). A methylation array was used for this analysis. Percent methylation within the TOMM40-APOE-APOC2 region was evaluated for differences according to tissue type, disease state, AD-related biomarkers, and gene expression. Results from this exploratory analysis suggest that regulatory element methylation levels within the larger TOMM40-APOE-APOC2 gene region correlate with AD-related biomarkers and TOMM40 or APOE gene expression in AD.Entities:
Mesh：
Substances：
Year: 2018 PMID： 29371683 PMCID： PMC6466631 DOI： 10.1038/s10038-017-0393-8
Source DB: PubMed Journal: J Hum Genet ISSN： 1434-5161 Impact factor: 3.172